Global Patent Index - EP 1423693 A1

EP 1423693 A1 20040602 - ERYTHROPOIETIN AND ANTI-TUMOR NECROSIS FACTOR ALPHA COMBINATION THERAPY

Title (en)

ERYTHROPOIETIN AND ANTI-TUMOR NECROSIS FACTOR ALPHA COMBINATION THERAPY

Title (de)

KOMBINATIONSTHERAPIE MIT ERYTHROPOETIN UND ANTI-TUMORNEKROSE-FAKTOR-ALPHA

Title (fr)

ERYTHROPOIETINE ET TRAITEMENT DE COMBINAISON ALPHA ANTI-FACTEUR DE NECROSE DES TUMEURS

Publication

EP 1423693 A1 20040602 (EN)

Application

EP 01959479 A 20010802

Priority

US 0124384 W 20010802

Abstract (en)

[origin: WO03012432A1] The present invention provides a method to treat anemic and non-anemic subjects having malignancies with a combination of EPO and an anti-Tumor Necrosis Factor compound such that there is a reduced need for transfusion and a greater hemoglobin level. The present invention provides a method to treat anemic and non-anemic subjects having malignancies with a combination of EPO and an anti-Tumor Necrosis Factor compound such that anemia may be successfully prevented or treated during the course of a chemotherapeutic regimen. The present invention provides a method to treat anemic and non-anemic subjects having malignancies with a combination of EPO and an anti-Tumor Necrosis Factor compound such that the patients show greater quality of life, show relief from fatigue symptoms, and show improvement in physical performance and well being.

IPC 1-7

G01N 33/00; A01K 67/00; A01K 67/033; A01K 67/027; A01N 43/04; A61K 31/70

IPC 8 full level

A61K 38/18 (2006.01); A61K 45/00 (2006.01); A01K 67/00 (2006.01); A01K 67/027 (2006.01); A01K 67/033 (2006.01); A01N 43/04 (2006.01); A61K 31/454 (2006.01); A61K 31/52 (2006.01); A61K 31/573 (2006.01); A61K 31/70 (2006.01); A61K 38/17 (2006.01); A61K 38/22 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 7/06 (2006.01); A61P 35/00 (2006.01); G01N 33/00 (2006.01)

CPC (source: EP)

A61K 31/454 (2013.01); A61K 31/52 (2013.01); A61K 31/70 (2013.01); A61K 38/1793 (2013.01); A61K 38/1816 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); A61P 7/06 (2017.12); A61P 35/00 (2017.12); C07K 2319/30 (2013.01)

C-Set (source: EP)

  1. A61K 31/454 + A61K 2300/00
  2. A61K 31/52 + A61K 2300/00
  3. A61K 31/70 + A61K 2300/00
  4. A61K 38/1816 + A61K 2300/00
  5. A61K 38/1793 + A61K 2300/00
  6. A61K 39/395 + A61K 2300/00

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 03012432 A1 20030213; CA 2456177 A1 20030213; EP 1423693 A1 20040602; EP 1423693 A4 20060607; JP 2004537569 A 20041216

DOCDB simple family (application)

US 0124384 W 20010802; CA 2456177 A 20010802; EP 01959479 A 20010802; JP 2003517575 A 20010802